1-8 of 8
Julia Foster
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Emergence of Chronic Myeloid Leukemia in Patients with Myeloproliferative Neoplasms: A Single-Institution Experience

Kevin C. Miller, Jennifer Lombardi Story, Julia Foster, Jenna A. Moran, Amir T. Fathi, Gabriela S. Hobbs
Journal: Blood
Blood (2022) 140 (Supplement 1): 12295–12296.
https://doi.org/10.1182/blood-2022-170986
Published: 2022
Journal Articles

Targeted FGFR Inhibition Results in Hematologic and Cytogenetic Remission in a Myeloid Neoplasm Driven By a Novel PCM1-FGFR1 Fusion: Data from an Expanded Access Program

Monica Kasbekar, Valentina Nardi, MD, Paola Dal Cin, Andrew M. Brunner, MD, Yi-Bin Chen, Christine Connolly, Amir T. Fathi, MD, Julia Foster, ANP, Molly Macrae, Steven L McAfee, MD, Kristin McGregor, Rupa Narayan, Aura Y. Ramos, Tina T. Som, RN, Megan Vartanian, RN, Robb S Friedman, MD, Karim Benhadji, MD MSC, Gabriela S. Hobbs, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 5371.
https://doi.org/10.1182/blood-2019-124100
Published: 2019
Journal Articles

Phase I Study of Ixazomib in Addition to Chemotherapy for the Treatment of Acute Myeloid Leukemia in Older Adults

Philip C. Amrein, MD, Eyal C. Attar, MD, Traci M. Blonquist, MS, Andrew M. Brunner, MD, Gabriela S. Hobbs, MD, Hanno Hock, MD PhD, Steven McAfee, MD, Jenna A. Moran, NP, Meghan Bergeron, Julia Foster, ANP, Christina Bertoli, Kristin McGregor, Molly Macrae, Meghan Burke, Tanya T. Behnan, BS, Tina T. Som, RN, Aura Y. Ramos, Megan K. Vartanian, RN, Jennifer Lombardi Story, Donna S Neuberg, ScD, Amir T. Fathi, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 4059.
https://doi.org/10.1182/blood-2018-99-117566
Published: 2018
Journal Articles

Phase I Study of Ixazomib in Addition to Chemotherapy for the Treatment of Acute Lymphoblastic Leukemia in Older Adults

Philip C. Amrein, MD, Karen K. Ballen, MD, Traci M. Blonquist, MS, Andrew M. Brunner, MD, Gabriela S. Hobbs, MD, Hanno Hock, MD PhD, Steven L McAfee, MD, Jenna A. Moran, NP, Meghan Bergeron, Julia Foster, ANP, Christina Bertoli, Kristin McGregor, Molly Macrae, Meghan Burke, Tanya T. Behnan, BS, Tina T. Som, RN, Aura Y. Ramos, Megan K. Vartanian, RN, Jennifer Lombardi Story, Christine Connolly, Donna S Neuberg, ScD, Amir T. Fathi, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 2704.
https://doi.org/10.1182/blood-2018-99-117506
Published: 2018
Journal Articles

Phase I Study of the Antibody-Drug Conjugate Brentuximab Vedotin Combined with Re-Induction Chemotherapy in Patients with CD30-Expressing Relapsed/Refractory Acute Myeloid Leukemia

Amir T. Fathi, MD, Traci M. Blonquist, MS, Ashkan Emadi, MD PhD, Andrew M. Brunner, MD, Gabriela S. Hobbs, MD, Hanno Hock, MD PhD, Steven L McAfee, MD, Robert P. Hasserjian, MD, Frederic I. Preffer, PhD, Jenna A. Moran, NP, Meghan Bergeron, Julia Foster, ANP, Christina Bertoli, Kristin McGregor, Kaitlyn Fishman, Molly Macrae, Meghan Burke, Tanya T. Behnan, BS, Tina T. Som, RN, Aura Y. Ramos, Megan K. Vartanian, RN, Jennifer Lombardi Story, Patricia Lesho, Vu H. Duong, MD, Mason Mann, Christopher Lescinskas, Christine Connolly, Donna S Neuberg, ScD, Karen K. Ballen, MD, Philip C. Amrein, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 1431.
https://doi.org/10.1182/blood-2018-99-115031
Published: 2018
Journal Articles

Phase II Clinical Trial of Alisertib, an Aurora a Kinase Inhibitor, in Combination with Induction Chemotherapy in High-Risk, Untreated Patients with Acute Myeloid Leukemia

Andrew M. Brunner, MD, Traci M. Blonquist, MS, Daniel J. DeAngelo, MD, Malgorzata McMasters, MD, Eric S. Winer, MD, Gabriela S. Hobbs, MD, Philip C. Amrein, MD, Hanno Hock, MD PhD, David P. Steensma, Jacqueline S. Garcia, Marlise R. Luskin, MD, Richard M. Stone, MD, Karen K. Ballen, MD, Jacalyn Rosenblatt, MD, David E. Avigan, MD, Steven L McAfee, MD, Jenna A. Moran, NP, Meghan Bergeron, Julia Foster, ANP, Christina Bertoli, Kristin McGregor, Kaitlyn Fishman, Molly Macrae, Meghan Burke, Tanya T. Behnan, BS, Tina T. Som, RN, Aura Y. Ramos, Megan K. Vartanian, RN, Nicole Nelson, Emma Logan, Jennifer Lombardi Story, Christine Connolly, Donna S Neuberg, ScD, Yi-Bin Chen, MD, Timothy A. Graubert, MD, Amir T. Fathi, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 766.
https://doi.org/10.1182/blood-2018-99-115145
Published: 2018
Journal Articles

Perceptions of Prognosis and Treatment Risk in Older Patients with Acute Myeloid Leukemia

Areej El-Jawahri, MD, Gregory A. Abel, MD, Joseph Greer, PhD, Amir T. Fathi, MD MD BS, David P. Steensma, MD, Thomas W. LeBlanc, MD MA, Daniel J. DeAngelo, MD, Martha Wadleigh, MD, Gabriela S. Hobbs, MD, Julia Foster, ANP, Andrew Mark Brunner, MD, Philip C. Amrein, MD, Richard M. Stone, MD, Jennifer S Temel, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 349.
https://doi.org/10.1182/blood.V130.Suppl_1.349.349
Published: 2017
Journal Articles

Prospective serial evaluation of 2-hydroxyglutarate, during treatment of newly diagnosed acute myeloid leukemia, to assess disease activity and therapeutic response

Brief Report
Amir T. Fathi, Hossein Sadrzadeh, Darrell R. Borger, Karen K. Ballen, Philip C. Amrein, Eyal C. Attar, Julia Foster, Meghan Burke, Hector U. Lopez, Christina R. Matulis, Katherine M. Edmonds, A. John Iafrate, Kimberly S. Straley, Katharine E. Yen, Samuel Agresta, David P. Schenkein, Cedric Hill, Ashkan Emadi, Donna S. Neuberg, Richard M. Stone, Yi-Bin Chen
Journal: Blood
Blood (2012) 120 (23): 4649–4652.
https://doi.org/10.1182/blood-2012-06-438267
Published: 2012
Includes: Supplemental data